Biocon gets nod to acquire stake in Biocon Biologics

31 Jan 2025 Evaluate

Biocon has received approval for purchase of equity shares of Biocon Biologics (BBL), a material subsidiary of the Company, from one of its existing investors pursuant to liquidity option exercised by them. This would result in an increase in the company’s equity shareholding in BBL by 1.5%. Post this purchase, Biocon’s stake in BBL will be 90.2%.

Cost of acquisition is Rs 555 crore. The purchase shall be completed on or before February 01, 2025, subject to the completion of necessary formalities. The Board of Directors at its meeting held on January 30, 2025, has approved the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×